The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD) - Laura Orsolini; Alessandro Valchera; Duccio Papanti; R. Vecchiotti; Domenico De Berardis (European Psychiatry, 2016)

Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior - Johns Hopkins University (ClinicalTrials.gov, 2016)

Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache. - Davenport WJ (CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016)

The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey. - Di Lorenzo C; Coppola G; Di Lorenzo G; Bracaglia M; Rossi P; Pierelli F (Cephalalgia: an international journal of headache, 2016)

Classic hallucinogens in the treatment of addictions. - Bogenschutz MP; Johnson MW (Progress in neuro-psychopharmacology & biological psychiatry, 2016)

MAGIC MUSHROOM AND ITS EFFECTIVENESS - C. Meribha Christy (International Journal of Pharma and Bio Sciences, 2016)

MEMO ON THE RELIGIOUS IMPLICATIONS OF THE CONSCIOUSNESS-CHANGING DRUGS (LSD, Mescalin, Psilocybin) - Joseph Havens (Journal for the Scientific Study of Religion, 2016)

Psilocybin, LSD, Mescaline and drug-induced synesthesia - Dimitria Electra Gatzia; Berit Brogaard (PhilPapers (PhilPapers Foundation), 2016)

The epistemic innocence of psychedelic states. - Letheby C (Consciousness and cognition, 2016)

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. - Kraehenmann R; Schmidt A; Friston K; Preller KH; Seifritz E; Vollenweider FX (NeuroImage. Clinical, 2016)

Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics. - Tófoli LF; de Araujo DB (International review of neurobiology, 2016)

Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans. - Shebloski KL; Broadway JM (Frontiers in psychology, 2016)

The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving. - Sweat NW; Bates LW; Hendricks PS (Journal of psychoactive drugs, 2016)

HPLC Analysis of Hallucinogenic Mushroom Alkaloids (Psilocin and Psilocybin) Applying Hydrophilic Interaction Chromatography (HILIC) - Nagy Julia; Veress Tibor (Journal of Forensic Research, 2016)

Motivationen und Morphologie des Freizeitgebrauchs von Psychedelika (LSD, Psilocybin-Pilze): eine qualitative Interviewstudie - Susanna Prepeliczay (University of Bremen, 2015)

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain - Spain Aisling; Howarth Clare; Khrapitchev Alexandre A.; Sharp Trevor; Sibson Nicola R.; Martin Chris (Neuropharmacology, 2015)

Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts - Albert Garcia-Romeu; Tehseen Noorani; Roland R. Griffiths; Matthew W. Johnson (Drug and Alcohol Dependence, 2015)

Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybin - Frederick S. Barrett; Matthew W. Johnson; Roland R. Griffiths (Drug and Alcohol Dependence, 2015)

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. - Barrett FS; Johnson MW; Griffiths RR (Journal of psychopharmacology (Oxford, England), 2015)

Comparative phenomenology of psilocybin experiences in research and non-research settings - Theresa M. Carbonaro; Margaret A. Klinedinst; Matthew W. Johnson; Roland R. Griffiths (Drug and Alcohol Dependence, 2015)

The Psyche in Psychedelic - Stephen Mo Hanan (Tikkun, 2015)

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. - Kraehenmann R; Preller KH; Scheidegger M; Pokorny T; Bosch OG; Seifritz E; Vollenweider FX (Biological psychiatry, 2015)

Lysergic Acid Diethylamide and Psilocybin Revisited. - Geyer MA (Biological psychiatry, 2015)

Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. - Kometer M; Pokorny T; Seifritz E; Volleinweider FX (Psychopharmacology, 2015)

A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State. - Lowe LM; Peterson BL; Couper FJ (Journal of analytical toxicology, 2015)

[Psilocybin - public available psychodysleptic]. - Dydak K; Śliwińska-Mossoń M; Milnerowicz H (Postepy higieny i medycyny doswiadczalnej (Online), 2015)

P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers - Katrin H. Preller; Thomas Pokorny; Rainer Krähenmann; Milan Scheidegger; I. Dziobek; Philipp Stämpfli; F.X. Vollenweider (European Neuropsychopharmacology, 2015)

Psilocybin, psychological distress, and suicidality. - Hendricks PS; Johnson MW; Griffiths RR (Journal of psychopharmacology (Oxford, England), 2015)

The hallucinogenic world of tryptamines: an updated review. - Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M (Archives of toxicology, 2015)

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. - Lebedev AV; Lövdén M; Rosenthal G; Feilding A; Nutt DJ; Carhart-Harris RL (Human brain mapping, 2015)

Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death. - Wiltshire PE; Hawksworth DL; Edwards KJ (Journal of forensic and legal medicine, 2015)

Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes. - Borovička J; Oborník M; Stříbrný J; Noordeloos ME; Parra Sánchez LA; Gryndler M (Persoonia, 2015)

Psilocybin-containing mushrooms, upper palaeolithic rock art and the neuropsychological model - Patricia A. Helvenston (Rock Art Research, 2015)

Legal highs: staying on top of the flood of novel psychoactive substances. - Baumeister D; Tojo LM; Tracy DK (Therapeutic advances in psychopharmacology, 2015)

Discovery of a new caerulescent Psilocybe mushroom in Germany: Psilocybe germanica sp.nov. - Jochen Gartz; Georg Wiedemann (Drug Testing and Analysis, 2015)

Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice - Zhuk Olga; Jasicka-Misiak Izabela; Poliwoda Anna; Kazakova Anastasia; Godovan Vladlena; Halama Marek; Wieczorek Piotr (Toxins, 2015)

5HT2a Receptors - a New Target for Depression? - D.J. Nutt (European Psychiatry, 2015)

The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making - Katrin H. Preller; Thomas Pokorny; Rainer Krähenmann; I. Dziobek; Philipp Stämpfli; F.X. Vollenweider (European Psychiatry, 2015)

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. - Bogenschutz MP; Forcehimes AA; Pommy JA; Wilcox CE; Barbosa PC; Strassman RJ (Journal of psychopharmacology (Oxford, England), 2015)

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. - Hendricks PS; Thorne CB; Clark CB; Coombs DW; Johnson MW (Journal of psychopharmacology (Oxford, England), 2015)

Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? - Majić T; Schmidt TT; Gallinat J (Journal of psychopharmacology (Oxford, England), 2015)

Psychedelics not linked to mental health problems or suicidal behavior: a population study. - Johansen PØ; Krebs TS (Journal of psychopharmacology (Oxford, England), 2015)

[Ilicit drugs frequently used by drug addicts]. - Cirriez JP (Journal de pharmacie de Belgique, 2015)

Analysis of Psilocin, Bufotenine and LSD in Hair - Martin Rafaela; Schürenkamp Jennifer; Gasse Angela; Pfeiffer Heidi; Köhler Helga (Journal of Analytical Toxicology, 2015)

Drug models of schizophrenia. - Steeds H; Carhart-Harris RL; Stone JM (Therapeutic advances in psychopharmacology, 2015)

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. - Halberstadt AL (Behavioural brain research, 2015)

PENGARUH PEMBERIAN EKSTRAK JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT TERHADAP RASA INGIN TAHU MENCIT SWISS WEBSTER YANG DIUKUR DENGAN MANUAL HOLE BOARD - Kenny Farisan Badri; Sigit Kirana Lintang Bhima; Tuntas Dhanardhono (Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal), 2015)

Hallucinogenic drugs in pre-Columbian Mesoamerican cultures. - Carod-Artal FJ (Neurologia (Barcelona, Spain), 2015)

Can psychedelic compounds play a part in drug dependence therapy? - Sessa B; Johnson MW (The British journal of psychiatry: the journal of mental science, 2015)

Recreational use, analysis and toxicity of tryptamines. - Tittarelli R; Mannocchi G; Pantano F; Romolo FS (Current neuropharmacology, 2015)

The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. - Palhano-Fontes F; Andrade KC; Tofoli LF; Santos AC; Crippa JA; Hallak JE; Ribeiro S; de Araujo DB (PloS one, 2015)

Restructuring consciousness -the psychedelic state in light of integrated information theory. - Gallimore AR (Frontiers in human neuroscience, 2015)

Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey. - Schindler EA; Gottschalk CH; Weil MJ; Shapiro RE; Wright DA; Sewell RA (Journal of psychoactive drugs, 2015)

Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and Psilocin - Veniero Gambaro; Gabriella Roda; Giacomo Luca Visconti; Sebastiano Arnoldi; Eleonora Casagni; Caterina Ceravolo; Lucia Dell’Acqua; Fiorenza Farè; Chiara Rusconi; Lucia Tamborini; Stefania Arioli; Diego Mora (Journal of Analytical & Bioanalytical Techniques, 2015)

Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats - Sakashita Yuichi; Abe Kenji; Katagiri Nobuyuki; Kambe Toshie; Saitoh Toshiaki; Utsunomiya Iku; Horiguchi Yoshie; Taguchi Kyoji (Biological ^|^ Pharmaceutical Bulletin, 2015)

Turn on and tune in to evidence-based psychedelic research - Ben Sessa (The Lancet Psychiatry, 2014)

Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenology - Theresa M. Carbonaro; Frederick S. Barrett; Matthew P. Bradstreet; Matthew W. Johnson; Katherine A. MacLean; Robert L. Jesse; Roland R. Griffiths (Drug and Alcohol Dependence, 2014)

The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin - Frederick S. Barrett; Matthew P. Bradstreet; Jeannie-Marie Leoutsakos; Matthew W. Johnson; Katherine A. MacLean; Robert L. Jesse; Roland R. Griffiths (Drug and Alcohol Dependence, 2014)

Homological scaffolds of brain functional networks. - Petri G; Expert P; Turkheimer F; Carhart-Harris R; Nutt D; Hellyer PJ; Vaccarino F (Journal of the Royal Society, Interface, 2014)

Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin. - Bernasconi F; Schmidt A; Pokorny T; Kometer M; Seifritz E; Vollenweider FX (Cerebral cortex (New York, N.Y.: 1991), 2014)

Pholiotina cyanopus, a rare fungus producingpsychoactive tryptamines - Marek Halama; Anna Poliwoda; Іzabela Jasicka-Misiak; Piotr Wieczorek; Ryszard Rutkowski (Open Life Sciences, 2014)

Enhanced repertoire of brain dynamical states during the psychedelic experience. - Tagliazucchi E; Carhart-Harris R; Leech R; Nutt D; Chialvo DR (Human brain mapping, 2014)

Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers. - Pichini S; Marchei E; García-Algar O; Gomez A; Di Giovannandrea R; Pacifici R (Journal of pharmaceutical and biomedical analysis, 2014)

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. - Johnson MW; Garcia-Romeu A; Cosimano MP; Griffiths RR (Journal of psychopharmacology (Oxford, England), 2014)

Hallucinogens induce a specific barcode of phosphorylation on the serotonin2A receptor that underlies a weaker receptor desensitization and internalization - Franck Vandermoere; Philippe Marin (Receptors & Clinical Investigation, 2014)

P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study - Rainer Kraehenmann; Katrin H. Preller; Erich Seifritz; F.X. Vollenweider (European Neuropsychopharmacology, 2014)

ENTHEOGENS, MYSTICISM, AND NEUROSCIENCE - Ron Cole-Turner (Zygon®, 2014)

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. - Baumeister D; Barnes G; Giaroli G; Tracy D (Therapeutic advances in psychopharmacology, 2014)

14C-Psilocin tissue distribution in pregnant rats after intravenous administration - Law Francis; Poon Grace; Chui Y. C.; He Shao-Xiong (Functional Foods in Health and Disease, 2014)

Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs. - Appendino G; Minassi A; Taglialatela-Scafati O (Natural product reports, 2014)

Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybin - Matthew P. Bradstreet; Matthew W. Johnson; Katherine A. MacLean; Roland R. Griffiths (Drug and Alcohol Dependence, 2014)

Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study - Albert Garcia-Romeu; Matthew W. Johnson; Roland R. Griffiths (Drug and Alcohol Dependence, 2014)

Psychedelics, Glutamate, and Neuroimaging Studies - Rafael G. dos Santos (Anesthesiology, 2014)

Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators - Johns Hopkins University (ClinicalTrials.gov, 2014)

The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat - Rambousek Lukas; Palenicek Tomas; Vales Karel; Stuchlik Ales (Frontiers in Behavioral Neuroscience, 2014)

Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists. - Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F (Molecular & cellular proteomics: MCP, 2014)

Synthesis, hydrolysis and stability of psilocin glucuronide - Martin Rafaela; Schürenkamp Jennifer; Pfeiffer Heidi; Lehr Matthias; Köhler Helga (Forensic Science International, 2014)

TINJAUAN PELAKSANAAN KETENTUAN PIDANA UNDANGUNDANG NOMOR 35 TAHUN 2009 TERHADAP PENYALAHGUNAAN MAGIC MUSHROOM - Damianus Diaz Ferianto (UAJY Repository (University of Southampton), 2014)

Psilocybin–summary of knowledge and new perspectives. - Tylš F; Páleníček T; Horáček J (European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology, 2014)

P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocin - Tyls F.; Palenicek T.; Novakova P.; Kaderabek L.; Fujakova M.; Kubesova A.; Horacek J. (European Neuropsychopharmacology, 2014)

Potential Therapeutic Effects of Psilocybin/Psilocin are Minimized While Possible Adverse Reactions are Overrated - dos Santos Rafael G. (Therapeutic Drug Monitoring, 2014)

Psychedelic Research Resurrected: The Contributions of Stanislav Grof - Charles S. Grob (CIIS Digital Commons (California Institute of Integral Studies), 2014)

Stanislav Grof's Contributions to FDA Drug Development Research with Psychedelics - Rick Doblin (CIIS Digital Commons (California Institute of Integral Studies), 2014)

My Experience as a Guide in the Johns Hopkins Psilocybin Research Project - Mary P Cosimano (MAPS Bulletin, 2014)

PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A 2014 REPORT - Robert L. Jesse; Roland R. Griffiths (Council on Spiritual Practices, 2014)

Magic Mushroom Growing Kits: A new method for infringement of the narcotic laws. - Faruk Aşıcıoğlu; Mustafa Okudan; Nilay Derman; Mahmut Koca (Turkish Journal of Forensic Medicine, 2014)

Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. - Winstock AR; Kaar S; Borschmann R (Journal of psychopharmacology (Oxford, England), 2014)

Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. - Hendricks PS; Clark CB; Johnson MW; Fontaine KR; Cropsey KL (Journal of psychopharmacology (Oxford, England), 2014)

The Heffter Research Institute: past and hopeful future. - Nichols DE (Journal of psychoactive drugs, 2014)

Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. - Garcia-Romeu A; Griffiths RR; Johnson MW (Current drug abuse reviews, 2014)

A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment. - Turton S; Nutt DJ; Carhart-Harris RL (Current drug abuse reviews, 2014)

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. - Carhart-Harris RL; Leech R; Hellyer PJ; Shanahan M; Feilding A; Tagliazucchi E; Chialvo DR; Nutt D (Frontiers in human neuroscience, 2014)

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers. - Roseman L; Leech R; Feilding A; Nutt DJ; Carhart-Harris RL (Frontiers in human neuroscience, 2014)

Psilocybin and Obsessive Compulsive Disorder. - Wilcox JA (Journal of psychoactive drugs, 2014)

EPA-0137 - EEG power spectra and connectivity changes in animal serotonergic and glutamatergic models of psychosis - implications for treatment - Tomáš Páleníček; Filip Tylš; M. Fujáková; Anna Kubešová; Pavlína Nováková; L. Kadeřábek; Martin Brunovský; Jiřı́ Horáček (European Psychiatry, 2013)

EPA-1211 - Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic action - Javier González-Maeso (European Psychiatry, 2013)

Literature review: Considerations for Psychedelic Research - Charlesice Hawkins (UC Merced Undergraduate Research Journal, 2013)

Altered states: psychedelics and anesthetics. - Icaza EE; Mashour GA (Anesthesiology, 2013)

Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. - Carhart-Harris RL; Leech R; Erritzoe D; Williams TM; Stone JM; Evans J; Sharp DJ; Feilding A; Wise RG; Nutt DJ (Schizophrenia bulletin, 2013)

Serotonergic hallucinogens as translational models relevant to schizophrenia. - Halberstadt AL; Geyer MA (The international journal of neuropsychopharmacology, 2013)

Exposure to Potent Hallucinogens in an Adolescent - Deepak Prabhakar (The Primary Care Companion For CNS Disorders, 2013)

Broadband cortical desynchronization underlies the human psychedelic state. - Muthukumaraswamy SD; Carhart-Harris RL; Moran RJ; Brookes MJ; Williams TM; Errtizoe D; Sessa B; Papadopoulos A; Bolstridge M; Singh KD; Feilding A; Friston KJ; et al. (The Journal of neuroscience: the official journal of the Society for Neuroscience, 2013)

Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. - Carhart-Harris RL; Brugger S; Nutt DJ; Stone JM (Journal of psychopharmacology (Oxford, England), 2013)

A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment. - Burdick BV; Adinoff B (The American journal of drug and alcohol abuse, 2013)

PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS - Robin Carhart-Harris (Journal of Neurology Neurosurgery & Psychiatry, 2013)

Identification of novel psychoactive drug use in Sweden based on laboratory analysis–initial experiences from the STRIDA project. - Helander A; Beck O; Hägerkvist R; Hultén P (Scandinavian journal of clinical and laboratory investigation, 2013)

Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. - Catlow BJ; Song S; Paredes DA; Kirstein CL; Sanchez-Ramos J (Experimental brain research, 2013)

Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol - Stebelska Katarzyna (Therapeutic Drug Monitoring, 2013)

Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. - Kometer M; Schmidt A; Jäncke L; Vollenweider FX (The Journal of neuroscience: the official journal of the Society for Neuroscience, 2013)

A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. - Hallock RM; Dean A; Knecht ZA; Spencer J; Taverna EC (Drug and alcohol dependence, 2013)

Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS - Martin Rafaela; Schürenkamp Jennifer; Gasse Angela; Pfeiffer Heidi; Köhler Helga (International Journal of Legal Medicine, 2013)

Activity and Enzyme Kinetics of Human UDP-Glucuronosyltransferases: Studies of Psilocin Glucuronidation and the Effects of Albumin on the Enzyme Kinetic Mechanism - Nenad Manevski (Työväentutkimus Vuosikirja, 2013)

Magic truffles or Philosopher's stones: a legal way to sell psilocybin? - Pellegrini M; Rotolo MC; Marchei E; Pacifici R; Saggio F; Pichini S (Drug testing and analysis, 2013)

Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin. - Young SN (Journal of psychiatry & neuroscience: JPN, 2013)

Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice. - Moreno JL; Holloway T; Rayannavar V; Sealfon SC; González-Maeso J (Neuroscience letters, 2013)

Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. - Bogenschutz MP (Current drug abuse reviews, 2013)

Animal models of serotonergic psychedelics. - Hanks JB; González-Maeso J (ACS chemical neuroscience, 2013)

The Use of Synthetic Cathinones and Tryptamines in a Psychiatric Population - lhsan M Salloum (Journal of Forensic Toxicology and Pharmacology, 2013)

DETEKSI PSILOCIN URIN PADA MENCIT SWISS WEBSTER TERHADAP PEMBERIAN JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT. - Mochamad Muntaha; Sigit Kirana Lintang Bhima; Tuntas Dhanardhono (Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal), 2013)

Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations - Michael Kometer; André Schmidt; Lutz Jäncke; Franz X. Vollenweider (Open MIND, 2013)

Substance use initiation: the role of simultaneous polysubstance use. - Olthuis JV; Darredeau C; Barrett SP (Drug and alcohol review, 2013)

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. - Schmidt A; Kometer M; Bachmann R; Seifritz E; Vollenweider F (Psychopharmacology, 2013)

Over 30 million psychedelic users in the United States. - Krebs TS; Johansen PØ (F1000Research, 2013)

Peak experiences of psilocybin users and non-users. - Cummins C; Lyke J (Journal of psychoactive drugs, 2013)

[Suicide under the influence of "magic mushrooms"]. - Müller K; Püschel K; Iwersen-Bergmann S (Archiv fur Kriminologie, 2013)

Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi. - Kosentka P; Sprague SL; Ryberg M; Gartz J; May AL; Campagna SR; Matheny PB (PloS one, 2013)

Methoxetamine (MXE)–a phenomenological study of experiences induced by a "legal high" from the internet. - Kjellgren A; Jonsson K (Journal of psychoactive drugs, 2013)

Psychedelics and mental health: a population study. - Krebs TS; Johansen PØ (PloS one, 2013)

Experienced drug users assess the relative harms and benefits of drugs: a web-based survey. - Carhart-Harris RL; Nutt DJ (Journal of psychoactive drugs, 2013)

Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia. - Brogaard B (Frontiers in human neuroscience, 2013)

[The impact of psilocybin on visual perception and spatial orientation–neuropsychological approach]. - Jastrzebski M; Bala A (Psychiatria polska, 2013)

Effects of psilocybin on the human brain functional network - Weissbart Hugo (Figshare, 2012)

Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. - Kometer M; Schmidt A; Bachmann R; Studerus E; Seifritz E; Vollenweider FX (Biological psychiatry, 2012)

Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. - Maclean KA; Leoutsakos JM; Johnson MW; Griffiths RR (Journal for the scientific study of religion, 2012)

A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability - Martin Rafaela; Schürenkamp Jennifer; Pfeiffer Heidi; Köhler Helga (International Journal of Legal Medicine, 2012)

A fatal case of 'magic mushroom' ingestion in a heart transplant recipient. - Lim TH; Wasywich CA; Ruygrok PN (Internal medicine journal, 2012)

Opening Doors of Perception: Psychedelic Drugs and End-of-Life Care - Norra MacReady (JNCI Journal of the National Cancer Institute, 2012)

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. - Reissig CJ; Carter LP; Johnson MW; Mintzer MZ; Klinedinst MA; Griffiths RR (Psychopharmacology, 2012)

Moral transhumanism: the next step. - Tennison MN (The Journal of medicine and philosophy, 2012)

Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases. - Licht CL; Christoffersen M; Okholm M; Damgaard L; Fink-Jensen A; Knudsen GM; Erritzoe D (Human psychopharmacology, 2012)

Spirituality and Hallucinogen Use: Results from a Pilot Study among College Students - Adam Stasko; Satya P. Rao; Amy Pilley (International Journal of Transpersonal Studies, 2012)

A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens - Ümit Sayın (NeuroQuantology, 2012)

Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms' - Jacomien Aleman; Mirjam Crul; Peter H. J. van der Voort; Eric J. F. Franssen (Netherlands Journal of Critical Care, 2012)

Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. - Johnson MW; Sewell RA; Griffiths RR (Drug and alcohol dependence, 2012)

Neuroimaging: a scanner, colourfully. - Roiser JP; Rees G (Current biology: CB, 2012)

Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology - Evan J. Kyzar; Christopher Collins; Jeremy Green; Siddharth Gaikwad; Andrew Roth; Louis Monnig; Mohamed El-Ounsi; Nicholas Capezio; Andrew J. Freeman; Ari Davis; Allan V. Kalueff (The FASEB Journal, 2012)

Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. - Schmidt A; Bachmann R; Kometer M; Csomor PA; Stephan KE; Seifritz E; Vollenweider FX (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2012)

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. - Carhart-Harris RL; Leech R; Williams TM; Erritzoe D; Abbasi N; Bargiotas T; Hobden P; Sharp DJ; Evans J; Feilding A; Wise RG; Nutt DJ (The British journal of psychiatry: the journal of mental science, 2012)

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. - Carhart-Harris RL; Erritzoe D; Williams T; Stone JM; Reed LJ; Colasanti A; Tyacke RJ; Leech R; Malizia AL; Murphy K; Hobden P; Evans J; et al. (Proceedings of the National Academy of Sciences of the United States of America, 2012)

Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. - Quednow BB; Kometer M; Geyer MA; Vollenweider FX (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2012)

GAMBARAN KARAKTERISTIK SOSIODEMOGRAFIK, TINGKAT PENGETAHUAN DAN POLA PENGGUNAAN JAMUR Psilocybin PADA MAHASISWA S1 UNIVERSITAS PADJAJARAN PERIODE AJAR2010-2011 - Natasha Amalda Ediwan (Universitas Padjadjaran Repository, 2012)

Flavone Glycoside Antagonizes Psilocybin-Induced Toxicity by Reducing Oxidative Stress in Rats Model - LI Yu-bai (Zhongguo Yike Daxue xuebao, 2012)

Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia - David Luke; Devin B. Terhune; Ross Friday (Seeing and Perceiving, 2012)

Prediction of psilocybin response in healthy volunteers. - Studerus E; Gamma A; Kometer M; Vollenweider FX (PloS one, 2012)

Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. - Lyvers M; Meester M (Journal of psychoactive drugs, 2012)

Study Suggests Hallucinogen May Be Personality Changer - Joan Arehart-Treichel (Psychiatric News, 2011)

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. - Griffiths RR; Johnson MW; Richards WA; Richards BD; McCann U; Jesse R (Psychopharmacology, 2011)

The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability. - Carhart-Harris RL; Williams TM; Sessa B; Tyacke RJ; Rich AS; Feilding A; Nutt DJ (Journal of psychopharmacology (Oxford, England), 2011)

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. - Studerus E; Kometer M; Hasler F; Vollenweider FX (Journal of psychopharmacology (Oxford, England), 2011)

Salvia divinorum use and phenomenology: results from an online survey. - Sumnall HR; Measham F; Brandt SD; Cole JC (Journal of psychopharmacology (Oxford, England), 2011)

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. - Halberstadt AL; Koedood L; Powell SB; Geyer MA (Journal of psychopharmacology (Oxford, England), 2011)

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. - MacLean KA; Johnson MW; Griffiths RR (Journal of psychopharmacology (Oxford, England), 2011)

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. - Halberstadt AL; Geyer MA (Neuropharmacology, 2011)

Iconography in Bradshaw rock art: breaking the circularity. - Pettigrew J (Clinical & experimental optometry, 2011)

Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms - Shoda Takuji; Fukuhara Kiyoshi; Goda Yukihiro; Okuda Haruhiro (Drug Testing and Analysis, 2011)

Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis - Chen Jianbo; Li Meijia; Yan Xitao; Wu Enqi; Zhu Hongmei; Lee Kwan Jun; Chu Van Men; Zhan Lifeng; Lee Wonjae; Kang Jong Seong (Journal of Chromatography B, 2011)

P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin - Robin Carhart-Harris; David Erritzøe; James Stone; Rjs Wise; David Nutt (European Neuropsychopharmacology, 2011)

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists. - Moreno JL; Holloway T; Albizu L; Sealfon SC; González-Maeso J (Neuroscience letters, 2011)

Harm potential of magic mushroom use: a review. - van Amsterdam J; Opperhuizen A; van den Brink W (Regulatory toxicology and pharmacology: RTP, 2011)

The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. - Kometer M; Cahn BR; Andel D; Carter OL; Vollenweider FX (Biological psychiatry, 2011)

Alternative headache treatments: nutraceuticals, behavioral and physical treatments. - Sun-Edelstein C; Mauskop A (Headache, 2011)

Biophotons, hallucinogens, and fluorescence - F. Grass (European Psychiatry, 2011)

Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring. - Moreno JL; Kurita M; Holloway T; López J; Cadagan R; Martínez-Sobrido L; García-Sastre A; González-Maeso J (The Journal of neuroscience: the official journal of the Society for Neuroscience, 2011)

Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. - Meyer MR; Maurer HH (Pharmacogenomics, 2011)

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. - Grob CS; Danforth AL; Chopra GS; Hagerty M; McKay CR; Halberstadt AL; Greer GR (Archives of general psychiatry, 2011)

Voice of the psychonauts: coping, life purpose, and spirituality in psychedelic drug users. - Móró L; Simon K; Bárd I; Rácz J (Journal of psychoactive drugs, 2011)

Heaven and hell–a phenomenological study of recreational use of 4-HO-MET in Sweden. - Kjellgren A; Soussan C (Journal of psychoactive drugs, 2011)

Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans - Matthew J. Baggott; Jennifer D. Siegrist; Gantt P. Galloway; Lynn C. Robertson; Jeremy Coyle; John Mendelson (PLoS ONE, 2010)

Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds. - Riley S; Thompson J; Griffin C (The International journal on drug policy, 2010)

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. - Vollenweider FX; Kometer M (Nature reviews. Neuroscience, 2010)

Psychometric evaluation of the altered states of consciousness rating scale (OAV). - Studerus E; Gamma A; Vollenweider FX (PloS one, 2010)

Determining the subjective effects of TFMPP in human males. - Jan RK; Lin JC; Lee H; Sheridan JL; Kydd RR; Kirk IJ; Russell BR (Psychopharmacology, 2010)

Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in mice - Thiago Berti Kirsten; Maria Martha Bernardi (Revista Brasileira de Farmacognosia, 2010)

The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects. - Butelman ER; Rus S; Prisinzano TE; Kreek MJ (Psychopharmacology, 2010)

Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin. - Wark C; Galliher JF (The International journal on drug policy, 2010)

Psilocybin Mushrooms of the World: an identification guide. Paul Stamets. - Guy A. Rutter (Edinburgh Journal of Botany, 2010)

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series - Matthias Karst; John H. Halpern; Michael Bernateck; Torsten Passie (Cephalalgia, 2010)

Psilocybin slows binocular rivalry switching through serotonin modulation - O. Carter; John D. Pettigrew; Felix Hasler; Guy Wallis; Franz X. Vollenweider (Journal of Vision, 2010)

Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors - Olivia Carter; David C. Burr; John D. Pettigrew; Franz X. Vollenweider (Journal of Vision, 2010)

ChemInform Abstract: Palladium-Catalyzed Synthesis of Tryptamines and Tryptamine Homologues: Synthesis of Psilocin. - Hu Chunmei; Qin Hua; Cui Yuxin; Jia Yanxing (ChemInform, 2010)

Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases - Manevski Nenad; Kurkela Mika; Höglund Camilla; Mauriala Timo; Court Michael H.; Yli-Kauhaluoma Jari; Finel Moshe (Drug Metabolism and Disposition, 2010)

Comparative study of ATR and transflection IR spectroscopic techniques for the analysis of hallucinogenic mushrooms. - Koçak A; De Cotiis LM; Hoffman DB (Forensic science international, 2010)

Forensic analysis of hallucinogenic mushrooms and khat (Catha edulis Forsk) using cation-exchange liquid chromatography. - Laussmann T; Meier-Giebing S (Forensic science international, 2010)

Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention - Matthew J. Baggott (eScholarship (California Digital Library), 2009)

Aspects of secondary metabolism in basidiomycetes: I. biological and biochemical studies on Psilocybe cubensis II. a survey of phenol-o-methyltransferase in species of Lentinus and Lentinellus - Weiwei Wang (cIRcle (University of British Columbia), 2009)

Current Research on the Human Experience of Spirituality Following the Ingestion of ‘Magic’ Psilocybin Mushrooms: An Annotated Bibliography for Social Workers and Other Health Care Professionals - Rose Jade (SSRN Electronic Journal, 2009)

Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan - Tooru Kamata; Munehiro Katagi; Hitoshi Tsuchihashi (Forensic Toxicology, 2009)

Detection of Psilocybin Mushroom Analogs in Chocolate - Brandon Huskins; Christopher R. Dockery (The Chemical Educator, 2009)

[Student's use of illicit drugs: a survey in a preventive health service]. - Morvan Y; Rouvier J; Olié JP; Lôo H; Krebs MO (L'Encephale, 2009)

Palladium-catalyzed synthesis of tryptamines and tryptamine homologues: synthesis of psilocin - Hu Chunmei; Qin Hua; Cui Yuxin; Jia Yanxing (Tetrahedron, 2009)